• FOx BIOSYSTEMS launches the White FOx, its new generation biosensor with fiber-optic surface plasmon resonance

    Thursday March 18th 2021

  • Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases

    Thursday March 18th 2021

  • eTheRNA extends leadership team with the appointment of Dr. Volker Germaschewski as Senior Vice President for R&D

    Thursday March 11th 2021

  • Complix signs global drug discovery and development agreement with I-Mab to develop cell penetrating alphabodies against two intracellular immuno-oncology targets

    Thursday March 11th 2021

  • AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan

    Wednesday March 10th 2021

  • VIB announces complete development of COVID-19 antibody, and its effectiveness against new variants

    Wednesday March 10th 2021

  • Mithra and Searchlight Pharma announce Estelle® approval in Canada

    Monday March 8th 2021

  • Cardiology prepared for fourth dimension

    Friday March 5th 2021

  • Your news here?

  • Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies

    Thursday March 4th 2021

  • argenx announces FDA acceptance of BLA filing for Efgartigimod for the treatment of generalized myasthenia gravis

    Wednesday March 3rd 2021

  • Mithra and Farmitalia announce commercial launch of Myring™ in Italy

    Wednesday March 3rd 2021


Strategic Partners